Tag Archives: SPET

NuGEN Technologies today announced that the United States Patent and Trademark Office has issued US Patent No. US 9,650,628 describing the Single Primer Target Enrichment Technology (SPET) which enables targeted nucleic acid analysis by next generation sequencing (NGS). NuGEN offers ...

Fusion genes are known to be key drivers of tumor growth in several types of cancer. Traditionally, detecting fusion genes has been a difficult task based on fluorescent in situ hybridization to detect chromosomal abnormalities. More recently, RNA sequencing has ...